IndraLab
Statements
sparser
"Nowadays, for the modification regulation of OTUB2, only SUMOylation of the Lys233 site of OTUB2 is confirmed to interact with Yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ), thereby enhancing the activity of OTUB2 and mediating the transfer of ubiquitin ( xref )."
sparser
"In mouse breast cancer cells, OTUB2 is SUMOylated at the Lys233 site after translation, and modified OTUB2 relies on this modification to interact with SUMO-interacting motif (SIM) of YAP/TAZ to perform its deubiquitination function, ultimately affecting cancer metastasis ( xref )."
sparser
"Ovarian tumor (OTU) domain-containing ubiquitin aldehyde-binding
protein 2 (OTUB2) is an active-site cysteine containing DUB. xref Recent research progress revealed that elevated
OTUB2 expression correlates with tumorigenesis and metastasis. xref − xref OTUB2 can promote tumorigenic progression of non-small cell lung
cancer cells through deubiquitination of U2AF2, stimulation of the
Warburg effect, and activation of AKT/mTOR signaling. xref Moreover, OTUB2 has been identified as a cancer stemness
and metastasis-promoting factor that deubiquitinates YAP/TAZ proteins
in breast cancer cells, whereby poly-SUMOylation on OTUB2 lysine 233
mediates the interaction with YAP/TAZ. xref These studies demonstrate OTUB2 to be a relevant therapeutic target,
and the development of OTUB2-specific inhibitors can potentially be
beneficial for cancer therapies."